Turkish Journal of Medical Sciences
Abstract
Background/aim: Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation. The study aimed to assess serum 14-3-3eta, anti-CarP, and anti-Sa in seronegative RA (SNRA) patients who were treatment-naïve as well as in healthy subjects. This is the first study in the literature to examine these autoantibodies together in SNRA patients. Materials and methods: Forty-five treatment-naïve SNRA patients and 45 healthy subjects were recruited. Drugs change the levels of autoantibodies; therefore, patients who took any medication had been excluded from our study. Anti-carbamylated protein, anti-Sa, and 14-3-3eta were measured by using three different ELISA kits.Results: Median serum concentration of healthy controls in 14-3-3eta was 0.02 (0.02?0.27) ng/mL. Median serum concentration of SNRA patients in 14-3-3eta was 1.00 (0.48?1.28) ng/mL. Data were analyzed with Mann?Whitney U tests; the P-value was
DOI
10.3906/sag-1812-137
Keywords
14-3-3eta, Anti-carP, Anti Sa, seronegative
First Page
1498
Last Page
1502
Recommended Citation
SALMAN, E, ÇETİNER, S, BORAL, B, KİBAR, F, ERKEN, E, ERSÖZLÜ, E. D, BADAK, S. Ö, SALMAN, R. B, SERTDEMİR, Y, DURAN, A. Ç, & YAMAN, A (2019). Importance of 14-3-3eta, anti-CarP, and anti-Sa in the diagnosis of seronegative rheumatoid arthritis. Turkish Journal of Medical Sciences 49 (5): 1498-1502. https://doi.org/10.3906/sag-1812-137